文献速递乳房整形与再造美容整形

乳房假体引发局部与全身免疫反应:乳腺癌免疫监视的证据

Breast Implants Elicit Local and Systemic Immune Response: Evidence for Breast Cancer Immunosurveillance.
PubMed 文献 · Plast Reconstr Surg · 2024-09-30

研究比较首次隆乳(假体初治)与修复性隆乳(假体暴露)女性的血液和乳腺组织,发现假体暴露者针对黏蛋白-1、雌激素受体-α和乳腺珠蛋白A的抗体水平更高,乳腺组织中B细胞活化等免疫通路上调,提示假体周围炎症可延伸至乳腺实质并伴随更活跃的B细胞反应。

要点

  • 假体暴露女性对黏蛋白-1、雌激素受体-α和乳腺珠蛋白A的抗体水平高于假体初治女性。
  • 假体暴露者乳腺组织中黏蛋白-1表达更高,B细胞活化与发育等通路上调。
  • 首次证明假体周围炎症可延伸至乳腺实质,乳腺实质B细胞更活化。

核心结论

  • 假体周围炎症可延伸至乳腺实质,假体暴露女性乳腺实质B细胞更活化且对乳腺癌抗原抗体反应升高。

研究设计与样本

  • 研究纳入首次隆乳(假体初治,n=117)与修复性隆乳(假体暴露,n=71)女性共188例,采集血液和乳腺组织。
  • 采用酶联免疫吸附试验定量血清乳腺癌蛋白抗体,逆转录聚合酶链反应定量组织免疫相关基因表达,批量RNA测序识别差异表达基因与信号通路。

主要发现

  • 假体暴露患者对黏蛋白-1、雌激素受体-α和乳腺珠蛋白A的抗体水平高于假体初治患者。
  • 假体暴露患者乳腺组织中黏蛋白-1表达高于假体初治患者。
  • RNA测序显示假体暴露患者乳腺组织中B细胞活化与发育、T辅助细胞2型相关基因、T细胞活化、趋化因子及对雌激素反应等通路上调。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women with cosmetic implants have lower rates of future breast cancer than the general population. The authors hypothesized that the implant foreign body response could induce a local protective anticancer immunosurveillance. The authors expanded on their previous finding, which showed that women with breast implants have elevated antibody responses to certain breast cancer proteins. METHODS: Blood samples and breast tissue were collected from women undergoing first time breast augmentation (implant-naive [IN]) and revision breast augmentation (implant-exposed [IE]). Sera were collected and antibody levels to common breast cancer proteins were quantified by enzyme-linked immunosorbent assay. Reverse transcriptase-polymerase chain reaction was performed on breast tissue samples to quantify immune-related gene expression levels between IN and IE patients. Bulk RNA sequencing was performed to identify differentially expressed genes and altered signaling pathways in the breasts of IN patients versus IE patients. RESULTS: In total, 188 patients were recruited (IN, n = 117; IE, n = 71). Data demonstrated that IE patients had higher levels of antibodies to mucin-1, estrogen receptor-α, and mammaglobin A compared with IN patients. Mucin-1 expression was found to be higher in IE compared with IN breast tissue. RNA- sequencing analysis demonstrated up-regulated pathways in IE breast tissue for B-cell activation and development, T-helper cell type 2-related genes, T-cell activation, chemotactic factors, and responses to estrogen. CONCLUSIONS: This is the first study to demonstrate that periimplant inflammation extends beyond the implant capsule to the breast parenchyma. Women with breast implants have more activated B cells in the breast parenchyma and elevated antibody responses to breast cancer antigen. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, V.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Timmerman R, Allison S, Dolivo D, et al. Breast Implants Elicit Local and Systemic Immune Response: Evidence for Breast Cancer Immunosurveillance. Plast Reconstr Surg. 2024. PMID: 40294644. doi:10.1097/PRS.0000000000011780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。